We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YYGH:NASDAQYY Group Holding Limited Analysis

Data as of 2026-06-18 - not real-time

$0.13

Latest Price

8/10Risk

Risk Level: High

Executive Summary

YY Group is trading at $0.13, far below its DCF fair value of $21.46, suggesting extreme undervaluation but the company posts negative operating (-30.6%) and profit margins (-37.4%), a trailing EPS of -21.98, and a debt‑to‑equity of 59.1, highlighting serious financial weakness. Technicals reinforce a mixed picture: the 20‑day SMA (0.209) and 50‑day SMA (0.824) sit well above the market price, the 30‑day RSI is 24.7 (deeply oversold), MACD shows a modest bullish histogram, and volume is rising, yet the overall trend remains bearish with a 30‑day volatility of ~250% and a beta of ~2.0, indicating a highly volatile, high‑beta stock.
Recent news shows YY Group is pushing growth engines – deploying Unitree G1 humanoid robots, launching a four‑module AI framework and “OpenClaw” AI across hotel clients, and securing a partnership with an international 5‑star hotel – moves that could broaden recurring revenue. However, the company has paused its ATM equity offering, hinting at financing constraints, and its market cap is only $0.56 M, underscoring liquidity risk despite increasing trading volume.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 3/10

Key Factors

  • Bearish price trend vs moving averages
  • Extremely high volatility and beta
  • Negative earnings and cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential revenue lift from AI and robot deployments
  • Paused ATM offering limiting capital access
  • Improving but still weak profitability metrics

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF valuation indicates massive upside
  • Strategic partnerships and AI product rollout
  • Long‑run industry tailwinds in integrated facility management

Key Metrics & Analysis

Financial Health

Revenue Growth44.20%
Profit Margin-37.42%
ROE-217.97%
ROA-35.42%
Debt/Equity59.06
P/B Ratio0.0
Op. Cash Flow$-1958742
Free Cash Flow$2.7M

Technical Analysis

TrendBearish
RSI24.7
Support$0.11
Resistance$0.70
MA 20$0.21
MA 50$0.82
MA 200$10.80
MACDBullish
VolumeIncreasing
Fear & Greed Index88.5

Valuation

Fair Value$21.46
GradeUndervalued
TypeGrowth

Risk Assessment

Beta2.00
Volatility249.89%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.